Please assess the completion status of the following clinical trial:

Trial Title: A Pivotal Study to Assess the InSpace™ Device for Treatment of Full Thickness Massive Rotator Cuff Tears

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Main Inclusion Criteria:~* Positive diagnostic imaging by MRI of the index shoulder indicating a full thickness Massive Rotator Cuff Tear (MRCT), measuring ≥ 5 cm in diameter involving ≥ two tendons (confirmed Intra-operatively)~* Functional deltoid muscle and preserved passive range of motion on physical examination~* Documented VAS score of \> 30 mm pain~* Failed non-operative treatment of at least 4 months~* Patient in general good health,independent, and can comply with all post-operative evaluations and visits.~Main Exclusion Criteria:~* Known allergy to the device material (copolymer of PLA and -ε-caprolactone)~* Evidence of the following conditions:~  1. significant gleno-humeral or acromiohumeral arthritis~ 2. full thickness cartilage loss as seen on MRI~ 3. gleno-humeral instability (excessive translation of the humeral head on the glenoid fossa)~ 4. pre-existing deltoid defect or deltoid palsy~ 5. major joint trauma, infection or necrosis~ 6. partial thickness tears of the supraspinatous~ 7. fully reparable rotator cuff tear \[Tear of less than 5 cm in diameter (or \< 4 cm2) with retractable tendon that can be fully repaired\]~* The subject requires concomitant subscapularis repair and/or labral repair~* Previous surgery of the index shoulder in the past 1 year, excluding diagnostic arthroscopy~* The subject's condition is bilateral and rotator cuff repair is scheduled or to be scheduled over the course of this study for the contra lateral shoulder~* Major medical condition that could affect quality of life and influence the results of the study (e.g. HIV or other immunosuppressive conditions, active malignancy in the past 5 years, acute MI, CVA, etc.)~* Documented evidence of a history of drug/alcohol abuse within 12 months of enrollment~* The subject's condition represents a worker's compensation case~* The subject is currently involved in a health-related litigation procedure~* Females of child-bearing potential who are pregnant or breastfeeding or plan to become pregnant during the course of the study~* Concurrent participation in any other investigational clinical study one month prior to enrollment or during the entire study period~* The subject has implanted metallic devices (e.g., cardiac pacemakers, insulin pumps, nerve stimulators), medically implanted clips or other electronically, magnetically or mechanically activated implants that would contraindicate undergoing a MRI scan or has claustrophobia that would inhibit ability to undergo a MRI scan .~* The subject is physically or mentally compromised (e.g., currently being treated for a psychiatric disorder, senile dementia, Alzheimer's disease, etc.), to the extent that the Investigator judges the subject to be unable or unlikely to remain compliant to follow-up~* The subject is receiving prescription narcotic pain medication for conditions unrelated to the index shoulder condition~* The subject currently has an acute infection in the area surrounding the surgical site.

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- InSpace implantation (Type: EXPERIMENTAL): Arthroscopic InSpace (Sub-acromial tissue spacer system) implantation
- Tendon Repair (Type: ACTIVE_COMPARATOR): Arthroscopic partial repair of rotator cuff

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: complete